{
    "relation": [
        [
            "Compartment",
            "S",
            "",
            "CG",
            "",
            "",
            "PGB",
            "",
            "MGB",
            "",
            "GRA",
            "G-CSF",
            "",
            ""
        ],
        [
            "Regulations",
            "proliferative fraction",
            "self-renewal probability",
            "proliferative fraction",
            "amplification",
            "transition time",
            "amplification",
            "transition time",
            "post-mitotic amplification",
            "transition time",
            "turn-over",
            "endogenous production",
            "specific degradation",
            "external applications"
        ],
        [
            "Regulator",
            "bone marrow content",
            "bone marrow content",
            "bone marrow content",
            "G-CSF",
            "G-CSF",
            "G-CSF",
            "G-CSF",
            "G-CSF",
            "G-CSF",
            "-",
            "late bone marrow cell stages",
            "GRA",
            "-"
        ]
    ],
    "pageTitle": "Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.",
    "title": "",
    "url": "http://www.biomedsearch.com/nih/Pharmacokinetic-dynamic-modelling-G-CSF/22846180.html",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042991076.30/warc/CC-MAIN-20150728002311-00249-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 322108027,
    "recordOffset": 322073474,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{142680=\u00a9 2009-2015 BioMedSearch.com. All rights reserved}",
    "textBeforeTable": "Major compartments of the pharmacokinetic model and corresponding regulations Table 1\u00a0 ] [TableWrap ID: T1 Tables Figure 10\u00a0 (Validation of model): Validation of the model on the basis of two datasets not used for model fitting. Solid line is the model prediction. Dots and dotted lines are the data and the interpolated data respectively. [Figure ID: F10] Figure 9\u00a0 (Ratio of granulocytes and leukocytes): Based on model simulations, the ratio of granulocytes and leukocytes under CHOP-14 chemotherapy is predicted. [Figure ID: F9] Figure 8\u00a0 (Comparison of model and data for chemotherapy scenarios): Comparison of model and data for the CHOP-21 regimen and time intensified CHOP-14 regimen supported by various Filgrastim and Pegfilgrastim schedules. The solid line is the model prediction. Dots are patient medians at corresponding time points and the grey lines mark the interquartile range of the data. All scenarios are based on the same model parameters. [Figure ID: F8] Figure 7\u00a0 (Effect of chemotherapy delay): Effect of the delay parameter of the chemotherapy studied for the CHOP regimen. [Figure ID: F7]",
    "textAfterTable": "Most of these compartments are mediated by G-CSF. A complete set of model equations can be found in the Additional file 1. [TableWrap ID: T2 ] Table 2\u00a0 Data sets utilized for the establishment and validation of the granulopoiesis model Type of data Disease G-CSF schedules Chemotherapy References Phase I studies with Filgrastim none single application 3, 5, 10 \u03bcg/kg none [31] none single application 5, 10 \u03bcg/kg none [60] \u00a0 none 10 applications 75, 150, 300, 600 \u03bcg none [61] \u00a0 none 14 applications 30, 300 \u03bcg none [62] \u00a0 none single application 4, 8 \u03bcg/kg",
    "hasKeyColumn": true,
    "keyColumnIndex": 1,
    "headerRowIndex": 0
}